HOME >> BIOLOGY >> NEWS
Study Reveals Cancer Role Of Mutated Gene

CHAPEL HILL, N.C. - Scientists at the University of North Carolina at Chapel Hill have discovered the molecular role in cancer development of a mutated tumor suppressor gene known as ARF.

The new findings help clarify why ARF is the second most frequently mutated gene in human cancers, appearing in 40 percent of malignancies, second only to the mutated tumor suppressor gene, p53.

According to a report in the journal Molecular Cell, published May 20, ARF normally prevents cellular transformation by preventing degradation of the p53 protein. It allows p53 to accumulate in the cell's nucleus where it functions to stop tumor cell growth.

"We previously reported our discovery that the ARF protein functions to suppress tumor growth by biochemically binding to another protein called MDM2," says Dr. Yue Xiong, assistant professor of biochemistry and biophysics at the UNC-CH School of Medicine. "Under normal conditions, MDM2 binds with p53 and takes it to the cellular cytoplasm for degradation. ARF will stop this process, accumulating p53 in the nucleus."

In the new study, Xiong and Dr.Yanping Zhang, a postdoctoral researcher in his laboratory at the UNC Lineberger Comprehensive Cancer Center, for the first time have described how a normally-functioning ARF does that. Essentially, it binds with MDM2 and p53 to form a structure called a nuclear body. This structure prevents MDM2 and p53 from leaving the nucleus and entering the cytoplasm, where the proteins would otherwise be degraded, broken down.

"When these proteins all come together, p53 cannot go from the nucleus to the cytoplasm. So ARF blocks p53 nuclear export," Xiong says.

The researchers also focused on what happens when ARF becomes mutated. They demonstrated for the first time how the ability of a mutated ARF to fulfill its tumor-suppressing role is impaired - a demonstration based on three discoveries.

First, Zhang and Xiong discovered that ARF is normally located in the cell's n
'"/>

Contact: Lynn Wooten
LWooten@unch.unc.edu
919-966-6046
University of North Carolina School of Medicine
21-May-1999


Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 11, 2020 , ... Both ... NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary to gain ... and J&J have annual Research and Development spending in excess of US $10 ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... company announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to provide ... clients to strengthen their laboratory supply chain for more than 10 years. Early ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. While ... global economic downturn will only increase price pressures overall for the industry. The era ... from every product launch is critical. However, history shows that only a third of ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... The ... the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), with ... network is a consortium of academic research centers in the United States and ...
(Date:8/12/2020)... ... August 12, 2020 , ... Inc. magazine today revealed that ... FDA compliance consulting has been named on its annual Inc. 5000 list, the ... unique look at the most successful companies within the American economy’s most dynamic ...
(Date:8/3/2020)... ... 03, 2020 , ... ERT, the global leader ... been named one of the 100 most inspiring individuals in the life-sciences industry ... selected based on how they have inspired their colleagues and affected positive changes ...
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive four ... may choose which extremities they would like treated. , Several studies have shown just ... R3 International, umbilical cord tissue is obtained from a lab with a long history ...
Breaking Biology Technology:
Cached News: